Can pharmacotherapy effectively reduce Alzheimer's related agitation?

Madia Lozupone; Maddalena La Montagna; Rodolfo Sardone; Davide Seripa; Antonio Daniele; Francesco Panza

doi:10.1080/14656566.2020.1770730

Can pharmacotherapy effectively reduce Alzheimer's related agitation?

Expert Opin Pharmacother. 2020 Sep;21(13):1517-1522. doi: 10.1080/14656566.2020.1770730. Epub 2020 Jun 1.

Authors

Madia Lozupone¹, Maddalena La Montagna², Rodolfo Sardone³, Davide Seripa^{4

5}, Antonio Daniele^{6

7}, Francesco Panza³

Affiliations

¹ Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro , Bari, Italy.
² Psychiatric Unit, Department of Clinical and Experimental Medicine, University of Foggia , Foggia, Italy.
³ Frailty Phenotypes Research Unit, "Salus in Apulia Study", National Institute of Gastroenterology "Saverio de Bellis", Research Hospital , Bari, Italy.
⁴ Geriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences, IRCCS "Casa Sollievo della Sofferenza" , Foggia, Italy.
⁵ Hematology and Stem Cell Transplant Unit, Vito Fazzi Hospital, ASL Lecce , Lecce, Italy.
⁶ Institute of Neurology, Catholic University of Sacred Heart , Rome, Italy.
⁷ Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome, Italy.

PMID: 32475180
DOI: 10.1080/14656566.2020.1770730

No abstract available

Keywords: Agitation; Alzheimer’s disease; aggression; amyloid-β; brexpiprazole; cannabinoids; citalopram; dextromethorphan/quinidine; electroconvulsive therapy; nabilone.

Publication types

Editorial